Combined Rapid Antigen Test COVID-19, Influenza A & B & RSV - 100 Units

"Our 100-unit pack of the COVID-19 Combined Rapid Antigen Test, Influenza A and B and Respiratory Syncytial Virus (RSV) from CorDx is an innovative solution for the rapid diagnosis of respiratory infections. Using a nasal swab sample, this assay provides accurate and reliable results in a matter of minutes. It is a valuable tool for medical professionals and patients seeking rapid and reliable detection of COVID-19, Influenza A and B and respiratory syncytial virus (RSV). The CorDx rapid combined antigen test complies with all necessary standards and regulations, including CE-IVD for use in the European Union and FDA for use in the United States. This guarantees the quality and accuracy of the test results.

• Sample collection from the anterior nasal area
• Store at room temperature (between 2° and 30°C).
• SARS-CoV-2: Sensitivity 94.23%, Specificity 100%.
• Influenza A: Sensitivity 100%, Specificity 99,82%.
• Influenza B: Sensitivity 98.90%, Specificity 99.94%.
• RSV: Sensitivity 99.82%, Specificity 99.78%.

Features:

- Easy to use with a single nasal swab.

- Results in a short time.

- High sensitivity and specificity.

- Detects COVID-19, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) in a single test.

- No additional equipment required for use.

- Convenient to carry with you anytime, anywhere.

Suitable for:

- Patients with respiratory symptoms.

- Medical professionals who need to make quick diagnoses.

- Medical and healthcare facilities looking for an efficient and accurate solution for diagnosing respiratory infections.

- People who travel frequently."